Brokerages forecast that Tyme Technologies Inc (NASDAQ:TYME) will report ($0.08) earnings per share for the current fiscal quarter, according to Zacks. Zero analysts have provided estimates for Tyme Technologies’ earnings. Tyme Technologies posted earnings per share of ($0.06) in the same quarter last year, which would suggest a negative year over year growth rate of 33.3%. The business is expected to report its next earnings report on Wednesday, February 6th.

According to Zacks, analysts expect that Tyme Technologies will report full-year earnings of ($0.30) per share for the current year. For the next year, analysts expect that the company will report earnings of ($0.37) per share. Zacks’ earnings per share averages are an average based on a survey of research firms that that provide coverage for Tyme Technologies.

Tyme Technologies (NASDAQ:TYME) last announced its earnings results on Monday, November 5th. The company reported ($0.07) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.08) by $0.01.

Several equities analysts recently weighed in on TYME shares. BidaskClub upgraded shares of Tyme Technologies from a “strong sell” rating to a “sell” rating in a report on Thursday, September 27th. Zacks Investment Research lowered shares of Tyme Technologies from a “buy” rating to a “hold” rating in a report on Thursday. Finally, HC Wainwright restated a “buy” rating and issued a $9.50 price objective on shares of Tyme Technologies in a report on Thursday, October 11th. One research analyst has rated the stock with a sell rating, two have given a hold rating and two have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $7.58.

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc lifted its holdings in Tyme Technologies by 60.1% in the third quarter. Vanguard Group Inc now owns 1,865,160 shares of the company’s stock valued at $5,186,000 after buying an additional 699,871 shares during the period. Vanguard Group Inc. increased its stake in Tyme Technologies by 60.1% in the third quarter. Vanguard Group Inc. now owns 1,865,160 shares of the company’s stock valued at $5,186,000 after purchasing an additional 699,871 shares in the last quarter. Renaissance Technologies LLC bought a new stake in Tyme Technologies in the third quarter valued at approximately $100,000. BlackRock Inc. increased its stake in Tyme Technologies by 3.6% in the third quarter. BlackRock Inc. now owns 2,065,741 shares of the company’s stock valued at $5,744,000 after purchasing an additional 71,188 shares in the last quarter. Finally, Wells Fargo & Company MN increased its stake in Tyme Technologies by 149.1% in the third quarter. Wells Fargo & Company MN now owns 266,026 shares of the company’s stock valued at $739,000 after purchasing an additional 159,251 shares in the last quarter. Institutional investors and hedge funds own 11.28% of the company’s stock.

Shares of TYME stock opened at $2.61 on Friday. Tyme Technologies has a 1 year low of $1.93 and a 1 year high of $7.00. The company has a market cap of $303.38 million, a PE ratio of -12.43 and a beta of 0.80.

About Tyme Technologies

Tyme Technologies, Inc, a clinical-stage biotechnology company, develops novel cancer therapeutics. It is developing SM-88, a combination therapy based on dysfunctional metyrosine derivatives in Phase II development for metastatic pancreatic cancer and biomarker-recurrent prostate cancer. The company was founded in 2011 and is headquartered in New York, New York.

See Also: What is the balance sheet?

Get a free copy of the Zacks research report on Tyme Technologies (TYME)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Tyme Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tyme Technologies and related companies with MarketBeat.com's FREE daily email newsletter.